You are here

Disarm Therapeutics

Eli Lilly Acquires Disarm Therapeutics in an Effort to Solve Axonal Degeneration

BioSpace

Thu, 10/15/20 - 10:17 pm

axonal degeneration

Disarm Therapeutics

Venturing Boldly Into Neuroscience

Forbes

Thu, 09/21/17 - 08:47 am

Disarm Therapeutics

Rodin Therapeutics

Lysosomal Therapeutics

Atlas ramps up a new biotech player focused on neurology, with a $30M round to fund the work

Endpoints

Tue, 09/19/17 - 10:15 pm

Disarm Therapeutics